Abvc Biopharma (ABVC) Preferred Dividend Payments (2010 - 2012)
Abvc Biopharma's (ABVC) quarterly Preferred Dividend Payments came in at -$32516.0 in Q2 2012, down 61.74% YoY from -$84984.6 in Q3 2011, and down 28.88% on a QoQ basis from -$25230.0 in Q1 2012.
Abvc Biopharma (ABVC) Preferred Dividend Payments (2010 - 2012) Analysis & Trends
Abvc Biopharma (ABVC) has 3 years of Preferred Dividend Payments data on file, last reported at -$32516.0 in Q2 2012.
- Quarterly Preferred Dividend Payments fell 61.74% year-over-year to -$32516.0 in Q2 2012, while the trailing twelve-month figure through Jun 2012 was $1.3 million (up 1270.53% YoY) and the FY2011 annual result came in at -$92497.0, up 50.41% from the prior year.
- Preferred Dividend Payments fell to -$32516.0 in Q2 2012, from -$25230.0 in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $1.4 million in Q3 2011 to a low of -$45181.0 in Q3 2010.
- A 3-year average of $129851.2 and a median of -$25230.0 in 2012 frame the typical range for Preferred Dividend Payments.
- Annual changes were most pronounced in 2011 — Preferred Dividend Payments surged 3211.57% — and 2012, when it tumbled 61.74%.
- Tracing ABVC's Preferred Dividend Payments over 3 years: stood at -$30972.0 in 2010, then gained by 29.7% to -$21772.0 in 2011, then plunged by 49.35% to -$32516.0 in 2012.
- The last three Preferred Dividend Payments figures came in at -$32516.0 (Q2 2012), -$25230.0 (Q1 2012), and -$21772.0 (Q4 2011), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Abvc Biopharma | 23.19 Mn | 23.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2012 | -32,516.00 |
| Mar 31, 2012 | -25,230.00 |
| Dec 31, 2011 | -21,772.00 |
| Sep 30, 2011 | 1.41 Mn |
| Jun 30, 2011 | -20,104.00 |
| Mar 31, 2011 | -17,052.00 |
| Dec 31, 2010 | -30,972.00 |
| Sep 30, 2010 | -45,181.00 |
| Jun 30, 2010 | -44,349.00 |